{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:10:58Z","timestamp":1789593058758,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Johns Hopkins\/UAB Cervical Cancer","award":["SPORE NCI 1 P50 CA098252"],"award-info":[{"award-number":["SPORE NCI 1 P50 CA098252"]}]},{"name":"NCI NExT Program","award":["#471"],"award-info":[{"award-number":["#471"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.ygyno.2015.11.026","type":"journal-article","created":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T22:51:17Z","timestamp":1448319077000},"page":"245-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"title":["A pilot study of pNGVL4a-CRT\/E7(detox) for the treatment of patients with HPV16 + cervical intraepithelial neoplasia 2\/3 (CIN2\/3)"],"prefix":"10.1016","volume":"140","clinical-trial-number":[{"clinical-trial-number":"nct00988559","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Ronald D.","family":"Alvarez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warner K.","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sejong","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Lawrence S.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Conner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenguang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Fu","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Paradis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"Hester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford E.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1623-4584","authenticated-orcid":false,"given":"T.C.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia L.","family":"Trimble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2015.11.026_bb0005","first-page":"149","article-title":"Control of HPV infection and related cancer through vaccination. Recent results in cancer research","volume":"193","author":"Tran","year":"2014","journal-title":"Fortschritte der Krebsforschung Progres dans les recherches sur le cancer"},{"key":"10.1016\/j.ygyno.2015.11.026_bb0010","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.vaccine.2013.10.081","article-title":"HPV vaccines to prevent cervical cancer and genital warts: an update","volume":"32","author":"Dochez","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2015.11.026_bb0015","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jnci\/djs491","article-title":"Annual report to the nation on the status of cancer, 1975\u20132009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels","volume":"105","author":"Jemal","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2015.11.026_bb0020","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/AOG.0b013e31828caa31","article-title":"Loop electrosurgical excision procedure and the risk for preterm delivery","volume":"121","author":"Heinonen","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.11.026_bb0025","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1158\/0008-5472.CAN-07-2754","article-title":"Type-dependent integration frequency of human papillomavirus genomes in cervical lesions","volume":"68","author":"Vinokurova","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2015.11.026_bb0030","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/sj.onc.1210791","article-title":"Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts","volume":"27","author":"Hafner","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2015.11.026_bb0035","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1128\/JVI.64.2.519-526.1990","article-title":"Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18","volume":"64","author":"Hudson","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.ygyno.2015.11.026_bb0040","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1126\/science.2157286","article-title":"Association of human papillomavirus types 16 and 18 E6 proteins with p53","volume":"248","author":"Werness","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.ygyno.2015.11.026_bb0045","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1172\/JCI200112346","article-title":"Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen","volume":"108","author":"Cheng","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ygyno.2015.11.026_bb0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0166-0934(03)00186-1","article-title":"Reproducibility of HPV 16 and HPV 18 viral load quantitation using TaqMan real-time PCR assays","volume":"112","author":"Gravitt","year":"2003","journal-title":"J. Virol. Methods"},{"issue":"40","key":"10.1016\/j.ygyno.2015.11.026_bb0055","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1016\/j.vaccine.2005.05.026","article-title":"Clinical safety and efficacy of a powdered hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device","volume":"23","author":"Roberts","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2015.11.026_bb0060","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-0684.2005.00124.x","article-title":"SIV DNA vaccine co-administered with IL-12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques","volume":"34","author":"Boyer","year":"2005","journal-title":"J. Med. Primatol."},{"key":"10.1016\/j.ygyno.2015.11.026_bb0065","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00262-007-0380-6","article-title":"Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC\/SVI)","volume":"57","author":"Janetzki","year":"2008","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ygyno.2015.11.026_bb0070","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.vaccine.2008.10.078","article-title":"Induction of antitumor immunity in vivo following delivery of a novel HPV-16 DNA vaccine encoding an E6\/E7 fusion antigen","volume":"27","author":"Yan","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2015.11.026_bb0075","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1016\/j.vaccine.2008.03.069","article-title":"Cellular immunity induced by a novel HPV18 DNA vaccine encoding an E6\/E7 fusion consensus protein in mice and rhesus macaques","volume":"26","author":"Yan","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2015.11.026_bb0080","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007323","article-title":"Intramuscular therapeutic vaccination targeting HPV16 induces T cell responses that localize in mucosal lesions","volume":"6","author":"Maldonado","year":"2014","journal-title":"Sci. Trans. Med."},{"key":"10.1016\/j.ygyno.2015.11.026_bb0085","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1067\/mob.2003.256","article-title":"Immunotherapy of human cervical high-grade cervical intraepithelial neoplasia with microparticle-delivered human papillomavirus 16 E7 plasmid DNA","volume":"188","author":"Sheets","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.11.026_bb0090","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/01.AOG.0000110246.93627.17","article-title":"ZYC101a for treatment of high-grade cervical intraepithelial neoplasia: a randomized controlled trial","volume":"103","author":"Garcia","year":"2004","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.11.026_bb0095","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cellimm.2011.04.005","article-title":"Immunization with a poly (lactide co-glycolide) encapsulated plasmid DNA expressing antigenic regions of HPV 16 and 18 results in an increase in the precursor frequency of T cells that respond to epitopes from HPV 16, 18, 6 and 11","volume":"270","author":"Matijevic","year":"2011","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.ygyno.2015.11.026_bb0100","unstructured":"Bodles-Brakhop AM, Heller R, Draghia-Akli R. Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments. Mol. Ther. 2009;17:585\u201392."},{"key":"10.1016\/j.ygyno.2015.11.026_bb0105","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004414","article-title":"Immunotherapy against HPV16\/18 generates potent TH1 and cytotoxic cellular immune responses","volume":"4","author":"Bagarazzi","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ygyno.2015.11.026_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(15)00239-1","article-title":"Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2\/3: a randomised, double-blind, placebo-controlled phase 2b trial","author":"Trimble","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2015.11.026_bb0115","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1158\/1078-0432.CCR-08-1725","article-title":"A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2\/3","volume":"15","author":"Trimble","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2015.11.026_bb0120","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007323","article-title":"Intramuscular therapeutic vaccination targeting HPV16 induces T cell responses that localize in mucosal lesions","volume":"6","author":"Maldonado","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ygyno.2015.11.026_bb0125","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nri1310","article-title":"Immune surveillance in the skin: mechanisms and clinical consequences","volume":"4","author":"Kupper","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ygyno.2015.11.026_bb0130","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.molimm.2004.06.040","article-title":"Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues","volume":"42","author":"Ebert","year":"2005","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ygyno.2015.11.026_bb0135","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1084\/jem.20032177","article-title":"A skin-selective homing mechanism for human immune surveillance T cells","volume":"199","author":"Schaerli","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ygyno.2015.11.026_bb0140","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.4049\/jimmunol.176.7.4431","article-title":"The vast majority of CLA+ T cells are resident in normal skin","volume":"176","author":"Clark","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.ygyno.2015.11.026_bb0145","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00262-009-0806-4","article-title":"Naturally occurring systemic immune responses to HPV antigens do not predict regression of CIN2\/3","volume":"59","author":"Trimble","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ygyno.2015.11.026_bb0150","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.it.2004.04.011","article-title":"The immunobiology of the TLR9 subfamily","volume":"25","author":"Wagner","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ygyno.2015.11.026_bb0155","doi-asserted-by":"crossref","unstructured":"Chuang CM, Monie A, Hung CF, Wu TC. Treatment with imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccination. J. Biomed. Sci. 2010 Apr 28;17:32. doi:http:\/\/dx.doi.org\/10.1186\/1423-0127-17-32.","DOI":"10.1186\/1423-0127-17-32"},{"key":"10.1016\/j.ygyno.2015.11.026_bb0160","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/sj.bjc.6605611","article-title":"Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulva intraepithelial neoplasia","volume":"102","author":"Daayana","year":"2010","journal-title":"Br. J. Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815301980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815301980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T19:17:05Z","timestamp":1599851825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825815301980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0090825815301980"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.11.026","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pilot study of pNGVL4a-CRT\/E7(detox) for the treatment of patients with HPV16+ cervical intraepithelial neoplasia 2\/3 (CIN2\/3)","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.11.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}